companies / biotts-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-13 json
| total_raised | 2,700,0002.7M | ○ |
|---|---|---|
| founded | 2018 | |
| hq | Wroclaw | |
| industry | unknown | |
| stage | null |
Biotts develops Multifunctional Transdermal Carrier technology that delivers small and large drug molecules through the skin without injections. It serves pharma and biotech partners reformulating injectables into patches and topicals to improve patient adherence. The MTC platform can move proteins as large as 150 kDa across skin, a size range conventional transdermal patches simply cannot deliver.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2026-04-23 | grant | 2,700,0002.7M | null | ○ |
WordPress, Apache HTTP Server, Yoast SEO 27.6, Google Analytics, Google Tag Manager, Site Kit 1.179.0, DoubleClick Floodlight, Contact Form 7 6.1.6, PHP, MySQL, apache
| fact | status | src |
|---|---|---|
| Grant, $2.7M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |